glp-1/gip + b12 longevity microdose GLP-1 (Tirzepatide) – BloomMD GLP-1/GIP + B12

O.et al

How can we avoid weight regain after stopping GLP-1 receptor agonists

Researchers recently examined how GLP-1 affects invariant natural killer T cells and found that this medication might regulate immune equilibrium beyond its metabolic effects [68]

It is still important for patients taking GLP-1 medication to limit muscle wasting through exercise and high quality protein. Losing muscle can lower metabolic rate and physical strength

Therefore, slowed gastric emptying from the stomach to the upper intestine (duodenum) observed after GLP-1 agonist administration could lead to increased levels of acetaldehyde and an altered or blunted rise in blood alcohol content (BAC)

Vomiting : This may occur alongside nausea, particularly in the early stages of use